Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.55 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.55 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | SELP | P16109 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31672996 | 0.94 | MAPT (0.55) | HDAC3MAPK1ADRA1AHDAC4SLC6A3 | |
| SCHEMBL490873 | 0.87 | KEAP1 (0.52) | MAPK1SMN1; SMN2HSD17B10MAPTSELP | |
| SCHEMBL9244332 | 0.82 | MAPT (0.47) | HDAC3MAPK1ADRA1AHDAC4SLC6A3 | |
| SCHEMBL6353317 | 0.81 | HDAC3 (0.57) | HDAC3MAPK1ADRA1AHDAC4SLC6A3 | |
| SCHEMBL10697891 | 0.80 | SMN1; SMN2 (0.52) | HDAC3MAPK1ADRA1AHDAC4SLC6A3 | |
| SCHEMBL18788836 | 0.80 | IGF1R (0.67) | HDAC3MAPK1ADRA1AHDAC4SLC6A3 | |
| SCHEMBL9861837 | 0.80 | HDAC3 (0.52) | HDAC3MAPK1ADRA1AHDAC4SLC6A3 | |
| SCHEMBL24264807 | 0.78 | SMN1; SMN2 (0.53) | HDAC3MAPK1ADRA1AHDAC4SLC6A3 | |
| SCHEMBL3197224 | 0.77 | SELP (0.43) | ADRA1ASLC6A3SELPSELESELL | |
| SCHEMBL8242449 | 0.77 | MAPT (0.55) | HDAC3MAPK1ADRA1AHDAC4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3496773-B1 | WETTING AGENT FORMULATION | Teleflex Life Sciences Llc (US) | 2025-12-17 | — | — | EP | disclosed |
| EP-3496772-B1 | METHOD FOR STERILIZING A MEDICAL DEVICE | Teleflex Life Sciences Llc (US) | 2025-11-26 | — | — | EP | disclosed |
| US-20230105383-A1 | WETTING AGENT FORMULATION | Teleflex Life Sciences Llc | 2023-04-06 | — | — | US | disclosed |
| US-11524096-B2 | Wetting agent formulation | TELEFLEX LIFE SCIENCES PTE. LTD. (SG) | 2022-12-13 | — | — | US | disclosed |
| US-20190216985-A1 | METHOD FOR STERILIZING A MEDICAL DEVICE | Teleflex Life Sciences Llc | 2019-07-18 | — | — | US | disclosed |
| EP-3496772-A1 | METHOD FOR STERILIZING A MEDICAL DEVICE | Teleflex Lifesciences (BM) | 2019-06-19 | — | — | EP | disclosed |
| EP-3496773-A1 | WETTING AGENT FORMULATION | Teleflex Lifesciences (BM) | 2019-06-19 | — | — | EP | disclosed |
| US-20190167849-A1 | WETTING AGENT FORMULATION | Teleflex Life Sciences Llc | 2019-06-06 | — | — | US | disclosed |
| WO-2018028831-A1 | WETTING AGENT FORMULATION | TELEFLEX LIFESCIENCES (BM) | 2018-02-15 | — | — | WO | disclosed |
| WO-2018029279-A1 | METHOD FOR STERILIZING A MEDICAL DEVICE | TELEFLEX LIFESCIENCES (BM) | 2018-02-15 | — | — | WO | disclosed |
| EP-3281649-A1 | WETTING AGENT FORMULATION | Teleflex Lifesciences (BM) | 2018-02-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11524096-B2 | Wetting agent formulation | CTSA, GLA, MGAM | HDAC3 852/4885MAPK1 160/4885ADRA1A 1904/4885 |
| US-20230105383-A1 | WETTING AGENT FORMULATION | CTSA, GLA, CHIA | HDAC3 861/4885MAPK1 158/4885ADRA1A 1902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.